European Union Intellectual Property Office (EIUPO) has granted trademark registration for Tauriga Sciences Inc (OTCMKTS:TAUG)’s Tauri-Gum. According to a communiqué from Tauriga, the notice of allowance from EIUPO enhances the global value of Tauri-Gum.
Showcases Tauri-Gum at CBD Show
Tauriga will showcase its flagship brand – Tauri-Gum at a European CBD Show from May 1 to 3, 2020, in London, the UK. The product will receive global interest from European Distributors. Its trademark registration came into effect from February 18, 2020.
Progress in developing Tauri-Gum’s pharmaceutical version
Tauriga has achieved significant progress in developing Tauri-Gum’s pharmaceutical version. The company has established Tauriga Corporation, its wholly-owned subsidiary, to focus on the ongoing development of the product – Anti-Nausea product. The company already finalized the formula for this groundbreaking and innovative pharmaceutical grade of Tauri-Gum. It is now putting in efforts to obtain Intellectual Property rights for this innovative formulation. The company is also in discussions with the US FDA regarding this innovative product that shows significant business potential.
Retains the services of Lowenstein Sandler
Lowenstein Sandler, a law firm, will assist Tauriga in all regulatory matters relating to the development of a pharmaceutical version of Tauri—Gum. Tauriga is working with the heads of Lowenstein Sandler’s FDA Practice, Life Sciences Group, Chemicals & Life Sciences Patent Practice.
Tauriga is engaged in the CBD infused chewing gum product business. The company has branded this product under the name – Tauri-Gum. Tauriga offers Tauri-Gum in three distinct flavors, namely – Pomegranate, blood orange, and mint.
Tauriga has completed the initial production run of this flagship product on December 6, 2019. It has expanded the product line by introducing a gum drop (25mg Vegan CBD Isolate Infused vegan gummy) and branded under a name – Tauri-Gummies. The company will use its expertise and resources to develop a sustainable and diversified business model.
CBG Isolate infused version of Tauri-Gum
Tauriga is also developing CBD (Cannabigerol) Isolate infused Tauri-Gum. The company will offer this product in Peach and Starfruit flavors. It will include 10 mg of CBG Isolate in each piece of the Tauri-Gum. Also, the blister pack will comprise 80 mg of CBG isolate. Tauriga will commence the manufacturing of these innovative products in Q4 2020.